|
| 36691918 | Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease. | | 2023 |
| 36702559 | Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction. | | 2023 |
| 34562082 | Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5Â million individuals. | International Journal of Epidemiology | 2022 |
| 35452448 | Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries. | PLoS Medicine | 2022 |
| 36082669 | Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology. | Hypertension | 2022 |
| 35803063 | Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study. | Atherosclerosis | 2022 |
| 34910136 | Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. | Eur Heart J | 2022 |
| 34672391 | Robust estimates of heritable coronary disease risk in individuals with type 2 diabetes. | Genetic Epidemiology | 2022 |
| 33356370 | Lp(a) (Lipoprotein[a]), an Exemplar for Precision Medicine: Insights From UK Biobank. | Arteriosclerosis, Thrombosis, and Vascular Biology | 2021 |
| 32702748 | Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. | Eur Heart J | 2020 |
| 31968102 | Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol. | Brain | 2020 |
| 31331193 | Impact of ADCY9 Genotype on Response to Anacetrapib. | Circulation | 2019 |
| 30586705 | Genetically Determined Levels of Circulating Cytokines and Risk of Stroke. | Circulation | 2019 |
| 30821829 | Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials. | JAMA network open | 2019 |
| 31504423 | A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. | Eur Heart J | 2019 |
| 31447131 | Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial. | Clinical Therapeutics | 2019 |
| 30787162 | Relative effects of LDL-C on ischemic stroke and coronary disease: A Mendelian randomization study. | Neurology | 2019 |
| 29740026 | Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer's disease. | Scientific Reports | 2018 |
| 29020353 | Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke. | Eur Heart J | 2018 |
| 30510157 | GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes. | Nat Commun | 2018 |
| 30170852 | Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. | Lancet | 2018 |
| 29449329 | Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study. | Circulation. Genomic and precision medicine | 2018 |
| 29713486 | Plasma cytokines and risk of coronary heart disease in the PROCARDIS study. | Open Heart | 2018 |
| 29378781 | The role of lipoprotein (a) in chronic kidney disease. | Journal of Lipid Research | 2018 |
| 28714975 | Association analyses based on false discovery rate implicate new loci for coronary artery disease. | Nat Genet | 2017 |
| 28459806 | Identifying systematic heterogeneity patterns in genetic association meta-analysis studies. | PLoS Genetics | 2017 |
| 28944551 | Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables. | Genet Epidemiol | 2017 |
| 28454801 | Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics. | Am Heart J | 2017 |
| 28416818 | Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. | Nat Genet | 2017 |
| 28847206 | Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. | N Engl J Med | 2017 |
| 27731410 | No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis. | Sci Rep | 2016 |
| 26935894 | Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration. | Neurology | 2016 |
| 27094995 | Emerging Risk Factors for Stroke: What Have We Learned From Mendelian Randomization Studies? | Stroke | 2016 |
| 26732560 | Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2. | Stroke | 2016 |
| 27407053 | Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs. | Circ Cardiovasc Qual Outcomes | 2016 |
| 26821629 | Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. | J Am Coll Cardiol | 2016 |
| 26821299 | Genetic loci on chromosome 5 are associated with circulating levels of interleukin-5 and eosinophil count in a European population with high risk for cardiovascular disease. | Cytokine | 2016 |
| 26343387 | A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. | Nat Genet | 2015 |
| 25613305 | Genetic overlap between diagnostic subtypes of ischemic stroke. | Stroke | 2015 |
| 25853659 | Genetically determined height and coronary artery disease. | N Engl J Med | 2015 |
| 25934857 | Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. | Neurology | 2015 |
| 26390057 | Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. | Nat Genet | 2015 |
| 24925971 | A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk. | Arteriosclerosis, Thrombosis, and Vascular Biology | 2014 |
| 25313593 | Pharmacogenomics of statin therapy: any new insights in efficacy or safety? | Current Opinion in Lipidology | 2014 |
| 24262325 | Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. | Stroke | 2014 |
| 24372611 | Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease. | Journal of Internal Medicine | 2014 |
| 25031287 | Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. | Neurology | 2014 |
| 25014686 | Effects of extended-release niacin with laropiprant in high-risk patients. | N Engl J Med | 2014 |
| 23202125 | Large-scale association analysis identifies new risk loci for coronary artery disease. | Nat Genet | 2013 |
| 23995691 | A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. | Nature | 2013 |